Non-invasive imaging of high-risk coronary plaque: The role of computed tomography and positron emission tomography

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Despite recent advances, cardiovascular disease remains the leading cause of death globally. As such, there is a need to optimise our current diagnostic and risk stratification pathways in order to better deliver individualised preventative therapies. Non-invasive imaging of coronary artery plaque can interrogate multiple aspects of coronary atherosclerotic disease, including plaque morphology, anatomy and flow. More recently, disease activity is being assessed to provide mechanistic insights into in vivo atherosclerosis biology. Molecular imaging using positron emission tomography is unique in this field, with the potential to identify specific biological processes using either bespoke or re-purposed radiotracers. This review provides an overview of non-invasive vulnerable plaque detection and molecular imaging of coronary atherosclerosis.

Cite

CITATION STYLE

APA

Bing, R., Loganath, K., Adamson, P., Newby, D., & Moss, A. (2020, September 1). Non-invasive imaging of high-risk coronary plaque: The role of computed tomography and positron emission tomography. British Journal of Radiology. British Institute of Radiology. https://doi.org/10.1259/bjr.20190740

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free